Desjardins-Innovatech
VC Fund
Montréal, Canada
Desjardins-Innovatech is a Canadian venture capital company that funds innovative businesses in diverse sectors across Quebec.
- Total investments:
- 23
- Last investment:
- Lead investor:
- 17%
Last updated:
For AI agents: llms.txt
Industries Desjardins-Innovatech invests in
Stages Desjardins-Innovatech invests in
Countries Desjardins-Innovatech invests in
Round sizes
Round size
- Seed
- $500k–$2.7M
- Series B
- $4.6M–$29M
- Venture - Series Unknown
- $365k–$10M
Investment Focus
Industry
- Health Care 8 (35%)
- Software 6 (26%)
- Manufacturing 4 (17%)
- Medical Device 3 (13%)
- SaaS 2 (9%)
Stage
- Seed 9 (39%)
- Series B 4 (17%)
- Venture - Series Unknown 4 (17%)
- Series A 3 (13%)
- Convertible Note 1 (4%)
Country
- Canada 18 (78%)
- Spain 1 (4%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Airex Energy has successfully developed an exciting new technology for biomass torrefaction. Based on a unique patented cyclonic bed reactor, CarbonFX enables large scale biocoal production from a variety of feedstock, including woody biomass and agricultural waste. | $27.4M / Series B / Mar 10, 2023 | ||
| Imagia's mission is to leverage advances in artificial intelligence and accelerate the advent of accessible personalized medicine.The company's platform leverage advances in artificial intelligence to provide outcome-based structured clinical data and federated learning capabilities across multiple sources while preserving privacy,enabling clinicians to drive end-to-end discoveries of predictive, diagnostic, and prescriptive analytics. | $17.1M / Series B / Sep 24, 2019 | ||
| LeddarTech provides the most flexible, robust and accurate sensing technology for advanced driver assistance systems (ADAS) and autonomous driving (AD). Our solutions enable customers to solve critical environmental sensing, fusion and perception challenges across the entire value chain.The company develops cost-effective perception solutionsscalable from Level 2 ADAS to Level 5 full autonomy with LeddarVision™, a raw-data sensor fusion and perception platform that generates a comprehensive 3D environmental model from a variety of sensor types (camera, radar and LiDAR) and configurations.LeddarTech’s disruptive technology reduces risks, accelerates development cycles and enables faster time-to-market. We are responsible for several cutting-edge remote-sensing innovations, with over 140 patents granted or applied for that enhance ADAS and autonomous driving capabilities.Our customers are OEMs and Tier 1-2 automotive suppliers looking for sensing and perception solutions that allow them to meet their key performance, cost and development time requirements for faster time-to-market and ROI. | $11.6M / Convertible Note / Nov 20, 2018 | ||
| Concentric develops ground-breaking agtech advancements that are safe for people, protect our natural resources and increase agriculture’s potential to feed the world. Concentric produces high-performance specialty biological products that naturally improve crop yields and replenish soils. | $15.9M / Series B / Apr 20, 2018 | ||
| Concentric develops ground-breaking agtech advancements that are safe for people, protect our natural resources and increase agriculture’s potential to feed the world. Concentric produces high-performance specialty biological products that naturally improve crop yields and replenish soils. | $9.6M / Series B / Jan 03, 2018 | ||
| A3 Surfaces Inc. offers a surface treatment service incorporating various antimicrobial agents directly into the anodized aluminum layer. The antimicrobial effect of these surfaces prevents the transmission of hospital-acquired infections. The technology used by A3 Surfaces offers antibacterial products that eradicate pathogens and can be used onall commercial, industrial or institutional surfaces. Founded in 2015, this Chicoutimi company employs 5 people. | Seed / Jan 01, 2018 | ||
| Provider of brain imaging platform created to help researchers get the most out of their medical images. The company's platform offers MRI high standing structure and deep learning algorithms, enabling pharmaceutical companies to quantity and understand brain connectivity and white matter. | $850K / Seed / Dec 10, 2017 | ||
| OxyNov is a young Canadian business focusing on clinical innovation and specialized in designing and commercializing innovative medical devices in the field of oxygen therapy and respiratory care. It was founded in 2009 by Professors Erwan L’Her (head of the Intensive Care Unit and INSERM researcher at the University Hospital of Brest) and FrançoisLellouche (intensivist and researcher at the IUCPQ -Quebec), further to a clinical research project having as an objective the development of a device automating the administration of oxygen therapy and the improvement of the application of this treatment on the daily basis | $364.7K / Venture - Series Unknown / May 10, 2017 | ||
| Laboratoire M2 manufactures innovative disinfection products from its proprietary platform named THYMOX TECHNOLOGY. Laboratoire M2 is also working on expanding its line of THYMOX TECHNOLOGY products and applications.the lab which has developed this technology branded as THYMOX.In order to ensure its exclusive ownership of the technology,Laboratoire M2 acquired the intellectual property rights to Thymox. The company holds Canadian and US and South-American patents on the product’s formulation and application, and has applied for patents in 40 other countries. | $4.6M / Series B / May 08, 2017 | ||
| Concentric develops ground-breaking agtech advancements that are safe for people, protect our natural resources and increase agriculture’s potential to feed the world. Concentric produces high-performance specialty biological products that naturally improve crop yields and replenish soils. | $29M / Series B / Mar 28, 2017 | ||
| See all 23 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Desjardins-Innovatech invest in?
Desjardins-Innovatech invests primarily in Health Care, Software and Manufacturing startups, most often at Seed and Series B stage. Most of the 23 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Desjardins-Innovatech's check size?
Desjardins-Innovatech typically joins rounds of $500k–$2.7M at Seed, $4.6M–$29M at Series B and $365k–$10M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Desjardins-Innovatech participates in.
When did Desjardins-Innovatech last invest?
The most recent investment recorded for Desjardins-Innovatech closed in Mar 2023. Shizune tracks 23 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
